Want to join the conversation?
$REGN announced a collaboration with Mitsubishi Tanabe Pharma Corp (MTPC) for providing MTPC exclusive development and commercial rights to fasinumab, an NGF antibody which is in late-stage development for musculoskeletal pain. MTPC will get exclusive development and commercial rights to fasinumab in 11 Asian countries, excluding China.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.